Research Analysts Set Expectations for ESPR FY2026 Earnings
Esperion Therapeutics, Inc. (NASDAQ:ESPR – Free Report) – Stock analysts at Cantor Fitzgerald issued their FY2026 EPS estimates for Esperion Therapeutics in a research note issued on Monday, June 9th. Cantor Fitzgerald analyst K. Kluska forecasts that the biopharmaceutical company will post earnings of $0.02 per share for the year. The consensus estimate for Esperion […]
Esperion Therapeutics, Inc. (NASDAQ:ESPR – Free Report) – Stock analysts at Cantor Fitzgerald issued their FY2026 EPS estimates for Esperion Therapeutics in a research note issued on Monday, June 9th. Cantor Fitzgerald analyst K. Kluska forecasts that the biopharmaceutical company will post earnings of $0.02 per share for the year. The consensus estimate for Esperion […]
